The Journal of Immunology · 2001 · 149 citations · 48 references
Life SciencesImmunologyOncologyApoptosisCancer ImmunologyImmunotherapyCytokines In Tumor ImmunityEffector T Cell FunctionInflammatory SignalingOxidative StressOxidative Stress MechanismsReactive Oxygen SpeciesImmune Cell Cytokine ProductionInflammatory Cytokine ProductionMacrophage Cytokine ProductionNf-κb SignalingOxidative Stress In CancerOxidative Stress In Immune DysfunctionOxidative Stress InjuryT Cell Cytokine Production
Impaired immune responses in cancer patients have been associated with oxidative stress. Increased levels of reactive oxygen species released from activated, tumor-infiltrating macrophages or granulocytes may therefore constitute a hurdle for effective immunotherapy against cancer. In this study, we investigated functional consequences and molecular events in T cells exposed to low levels of oxidative stress. We observed that cytokine production of human PBMC, upon stimulation with an HLA-A*0201-restricted influenza peptide and nonspecific receptor cross-linking, was reduced after exposure to micromolar levels of H2O2. Functional impairment as measured by IFN-gamma release occurred earlier and at lower doses of exogenously added H2O2 than required to induce apoptosis. This suggests that there is a dose window of oxidative stress leading to T cell unresponsiveness in the absence of apoptosis. The reduction of Th1 cytokines, induced by H2O2, was predominantly observed in memory/effector (CD45RO(+)) T cells and correlated with a block in NF-kappaB activation. IL-10 production was more profoundly influenced by low doses of H2O2 than IFN-gamma, TNF-alpha, and IL-2. The influence of H2O2 on production of IL-10 was not significantly different between memory/activated and naive T cells. These observations suggest that Th1 and Th2 cytokines are differently regulated under conditions of oxidative stress. Taken together, these findings may explain why Ag-experienced, CD45RO(+), T cells found in the tumor milieu are functionally suppressed.
48
Activators and target genes of Rel/NF-κB transcription factors
Heike L. Pahl · Oncogene · 1999 · 3.7K citations
Rosa Bacchetta, Mike Bigler, J.L. Touraine et al. · The Journal of Experimental Medicine · 1994 · 408 citations · Full text